Anaphylatoxin generation in acute pancreatitis

Area of Science:

• Immunology
• Gastroenterology
• Critical Care Medicine

Background:

• Acute pancreatitis is a serious condition often associated with systemic inflammation.
• Anaphylatoxins, such as C3a and C5a, are key mediators in inflammatory responses.
• Understanding the role of anaphylatoxins in pancreatitis can offer insights into disease pathogenesis and severity.

Purpose of the Study:

• To prospectively investigate the concentrations of anaphylatoxins (C3a and C5a) and their inactivator in patients with acute pancreatitis.
• To correlate anaphylatoxin levels with the clinical severity of acute pancreatitis, including the development of multisystem organ failure (MSOF).
• To assess the dynamic changes in anaphylatoxin levels during disease progression and recovery.

Main Methods:

• Prospective study of 51 patients diagnosed with acute pancreatitis.
• Measurement of plasma C3a and C5a concentrations using radioimmunoassay.
• Determination of anaphylatoxin inactivator activity.
• Classification of pancreatitis severity based on Ranson's criteria, peritoneal fluid, and MSOF.

Main Results:

• Elevated plasma C3a and C5a concentrations were observed during acute pancreatitis attacks.
• Anaphylatoxin levels showed a significant correlation with disease severity (C3a, P < 0.001; C5a, P < 0.05).
• Highest and most persistent anaphylatoxin levels were found in patients with MSOF; C3a levels decreased during recovery.

Conclusions:

• Elevated C3a and C5a levels are indicative of acute pancreatitis and correlate with its severity.
• Persistent anaphylatoxin elevation, particularly C3a, suggests ongoing inflammation or complications like abscess or pseudocyst.
• Anaphylatoxin measurements may serve as valuable biomarkers for assessing pancreatitis severity and guiding treatment decisions.